Drug Approval | December 04, 2023
AstraZeneca Pharma India receives permission from CDSCO to import new drug
The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India
The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India
Currently, Venkat is Lead – Market Access, India at Pfizer
The receipt of this permission paves way for the launch of Olaparib film coated tablets in India
Evinova will operate as a separate health-tech business within AstraZeneca
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
Nanoform will receive access to compound libraries and large data sets to undertake STARMAP screening
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
Currently, Praveen Akkinepally is the Head of Lung Cancer Commercialization, AstraZeneca Gaithersburg, MD, USA
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)